5-HT2 ligands in the treatment of anxiety and depression

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2012-10-12

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1517/13543784.2012.719872PMID 22917059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors.

  2025cited by this paper
• Blockade of the high‐affinity noradrenaline transporter (NET) by the selective 5‐HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

  2013cited by this paper
• Glial cells in adult neurogenesis

  2012cited by this paper
• Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review

  2012cited by this paper
• Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.

  2012influential reference
• Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.

  2012cited by this paper
• 5-HT2B receptors are required for serotonin-selective antidepressant actions

  2012cited by this paper
• Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response

  2012cited by this paper
• 5-HT 2B receptors are required for serotonin-selective antidepressants actions

  2012influential reference
• Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation.

  2012cited by this paper
• Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France

  2012cited by this paper
• Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression

  2012cited by this paper
• 5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.

  2011cited by this paper
• Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice

  2011influential reference
• Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.

  2011cited by this paper
• Lorcaserin: an investigational serotonin 2C agonist for weight loss.

  2011cited by this paper
• Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes

  2011cited by this paper
• Behavioral / Systems / Cognitive Serotonin-1 A Autoreceptors Are Necessary and Sufficient for the Normal Formation of Circuits Underlying Innate Anxiety

  2011cited by this paper
• Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT2B Receptors for Dexfenfluramine Anorectic Effects

  2011cited by this paper
• Animal models of neuropsychiatric disorders.

  2011cited by this paper
• 5-HT2C Receptors Localize to Dopamine and GABA Neurons in the Rat Mesoaccumbens Pathway

  2011cited by this paper
• Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex.

  2011cited by this paper
• Implication of 5-HT(2B) receptors in the serotonin syndrome.

  2011cited by this paper
• Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder.

  2011cited by this paper
• Deletion of ERK1 and ERK2 in the CNS Causes Cortical Abnormalities and Neonatal Lethality: Erk1 Deficiency Enhances the Impairment of Neurogenesis in Erk2-Deficient Mice

  2011cited by this paper
• Neurogenesis and affective disorders

  2011cited by this paper
• Efficacy markers in depression

  2011cited by this paper
• Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei.

  2011cited by this paper
• Comparative efficacy of escitalopram in the treatment of major depressive disorder

  2011cited by this paper
• Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression.

  2010cited by this paper
• 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress.

  2010cited by this paper
• Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.

  2010cited by this paper
• Therapeutic Potential of 5-HT2C Receptor Ligands

  2010cited by this paper
• Animal models of neuropsychiatric disorders

  2010cited by this paper
• Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

  2010cited by this paper
• Strain‐dependent serotonin neuron feedback control: role of serotonin2C receptors

  2010cited by this paper
• A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants.

  2010influential reference
• 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.

  2010cited by this paper
• Role of Serotonin in Central Dopamine Dysfunction

  2010cited by this paper
• 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.

  2010cited by this paper
• The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action.

  2010cited by this paper
• 5‐HT2C receptor activation prevents stress‐induced enhancement of brain 5‐HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment

  2010cited by this paper
• Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

  2010cited by this paper
• Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.

  2010cited by this paper
• Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

  2010cited by this paper
• The central serotonin2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity

  2010cited by this paper
• Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

  2010cited by this paper
• Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.

  2010influential reference
• Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high‐density schizophrenia families

  2009cited by this paper
• Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus

  2009cited by this paper
• Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A.

  2009cited by this paper
• Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI.

  2009cited by this paper
• Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice.

  2009influential reference
• Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors.

  2009cited by this paper
• Oppositional Effects of Serotonin Receptors 5-HT1a, 2, and 2c in the Regulation of Adult Hippocampal Neurogenesis

  2009influential reference
• The effects of the selective 5-HT2C receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats

  2009cited by this paper
• Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.

  2009influential reference
• Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation

  2009cited by this paper
• Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

  2009cited by this paper
• Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

  2009cited by this paper
• Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

  2009cited by this paper
• Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.

  2009cited by this paper
• Further pharmacological characterization of 5‐HT2C receptor agonist‐induced inhibition of 5‐HT neuronal activity in the dorsal raphe nucleus in vivo

  2009cited by this paper
• [Neurogenesis-dependent and independent effects of anti-depressant drugs].

  2009cited by this paper
• Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls.

  2009cited by this paper
• Serotonin (5‐HT) induces glial cell line‐derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells

  2008cited by this paper
• Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro

  2008cited by this paper
• Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation

  2008cited by this paper
• CNTF: A Putative Link between Dopamine D2 Receptors and Neurogenesis

  2008cited by this paper
• 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus.

  2008cited by this paper
• Partial remission, residual symptoms, and relapse in depression

  2008cited by this paper
• Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.

  2008cited by this paper
• Perspectives on genetic animal models of serotonin toxicity.

  2008cited by this paper
• Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors

  2008cited by this paper
• REGIONALLY-SPECIFIC REGULATION OF pERK1/2 MAP KINASE IN A MODEL OF ANTIDEPRESSANT-SENSITIVE CHRONIC DEPRESSION

  2008cited by this paper
• Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise

  2008cited by this paper
• Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors.

  2008cited by this paper
• Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress.

  2008cited by this paper
• S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

  2008influential reference
• MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes

  2007cited by this paper
• Augmentation of SSRI Effects on Serotonin by 5-HT2C Antagonists: Mechanistic Studies

  2007cited by this paper
• Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.

  2007cited by this paper
• Serotonin 5-HT(2C) receptors regulate anxiety-like behavior.

  2007cited by this paper
• Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.

  2007influential reference
• Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.

  2007cited by this paper
• Which antidepressants have demonstrated superior efficacy? A review of the evidence

  2007cited by this paper
• Serotonin 5‐HT2C receptors regulate anxiety‐like behavior

  2007cited by this paper
• WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity

  2007cited by this paper
• Distribution of serotonin 5-HT2C receptors in the ventral tegmental area.

  2007influential reference
• 5-HT2A Receptor Activation Leads to Increased BDNF mRNA expression in C6 glioma cells

  2007cited by this paper
• D2-Like Dopamine Receptors Depolarize Dorsal Raphe Serotonin Neurons through the Activation of Nonselective Cationic Conductance

  2007cited by this paper
• Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons

  2007cited by this paper
• HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study

  2007cited by this paper
• Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents

  2007influential reference
• Discontinuation symptoms in depression and anxiety disorders.

  2007cited by this paper
• Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

  2006cited by this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cited by this paper
• Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

  2006cited by this paper
• Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

  2006cited by this paper
• Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex

  2006cited by this paper

• Electroacupuncture stimulation of auricular concha region improves loss of control over stress induced depression-like behavior by modulating 5-hydroxytryptamine 1A receptor.

  2025cites this paper
• Anticonvulsant and anxiolytic-like potential of the essential oil from the Ocimum basilicum Linn leaves and its major constituent estragole on adult zebrafish (Danio rerio).

  2024cites this paper
• Social Isolation Induces Changes in the Monoaminergic Signalling in the Rat Medial Prefrontal Cortex

  2024cites this paper
• Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis

  2024cites this paper
• Absence of the Peptide Transporter 1 Induces a Prediabetic and Depressive-Like Phenotype in Mice

  2024cites this paper
• Norharmane potentiated anxiolytic- and antidepressant-like responses induced by imipramine and citalopram: an isobologram analysis

  2024cites this paper
• Trait sensitivity to negative feedback in rats is associated with increased expression of serotonin 5-HT2A receptors in the ventral hippocampus

  2023cites this paper
• Psychoactive substances 25H-NBOMe and 25H-NBOH induce antidepressant-like behavior in male rats.

  2023cites this paper
• The discovery of Fluroxene in depression treatment

  2022cites this paper
• Potential Pleiotropic Genes and Shared Biological Pathways in Epilepsy and Depression Based on GWAS Summary Statistics

  2022cites this paper
• Understanding the effects of serotonin in the brain through its role in the gastrointestinal tract.

  2022cites this paper
• Why the estrous cycle matters for neuroscience

  2022cites this paper
• Basolateral Amygdala Serotonin 2C Receptor Regulates Emotional Disorder-Related Symptoms Induced by Chronic Methamphetamine Administration

  2021cites this paper
• Serotonin 2A receptor polymorphism rs3803189 mediated by dynamics of default mode network: a potential biomarker for antidepressant early response.

  2021cites this paper
• Revisiting the behavioral genetics of serotonin: relevance to anxiety and depression

  2020cites this paper
• The anxiolytic effect of a promising quinoline containing selenium with the contribution of the serotonergic and GABAergic pathways: modulation of parameters associated with anxiety in mice.

  2020cites this paper
• Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice

  2020cites this paper
• Imaging serotonin and dopamine transporters in social anxiety disorder Characterization, treatment and expectancy effects

  2020cites this paper
• Insula serotonin 2A receptor binding and gene expression contribute to serotonin transporter polymorphism anxious phenotype in primates

  2019cites this paper
• Chromatin organization in the female mouse brain fluctuates across the oestrous cycle

  2019cites this paper
• 5-HT2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression

  2019cites this paper
• Effects of cognitive judgement bias and acute antidepressant treatment on sensitivity to feedback and cognitive flexibility in the rat version of the probabilistic reversal‐learning test

  2019cites this paper
• Serotonin Receptors of 5-HT2 Type in the Hypothalamic Arcuate Nuclei Positively Regulate Liver Cytochrome P450 via Stimulation of the Growth Hormone–Releasing Hormone/Growth Hormone Hormonal Pathway

  2018cites this paper
• 5-HT 2A Receptors and BDNF Regulation: Implications for Psychopathology

  2018cites this paper
• Ebselen has lithium‐like effects on central 5‐HT2A receptor function

  2018cites this paper
• Brain Circuits Regulated by the 5-HT 2A Receptor: Behavioural Consequences on Anxiety and Fear Memory

  2018cites this paper
• Synthesis of N -Alkyl-Carbazole Derivatives as 5-HT7 R Antagonists

  2018cites this paper
• Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice

  2018cites this paper
• Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

  2018cites this paper
• 5‐Hydroxytryptamine 2A receptors of the dorsal raphe nucleus modulate panic‐like behaviours and mediate fear‐induced antinociception elicited by neuronal activation in the central nucleus of the inferior colliculus

  2017cites this paper
• Serotonin 2A receptor (5-HT2A) gene promoter variant interacts with chronic perceived stress to modulate resting parasympathetic activity in humans.

  2017cites this paper
• Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine

  2017cites this paper
• 5-HT2A receptor deficiency alters the metabolic and transcriptional, but not the behavioral, consequences of chronic unpredictable stress

  2017cites this paper
• A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors

  2017cites this paper
• The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.

  2016cites this paper
• 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.

  2016cites this paper
• Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial

  2016cites this paper
• A single dose of mirtazapine attenuates neural responses to self-referential processing

  2016cites this paper
• Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies

  2016cites this paper
• Chapter 7 – Antidepressants

  2016cites this paper
• Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

  2015cites this paper
• Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.

  2015cites this paper
• Predicting targets of compounds against neurological diseases using cheminformatic methodology

  2015cites this paper
• Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test.

  2015cites this paper
• Polypharmacology of dopamine D1-like receptor antagonists

  2015cites this paper
• Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder.

  2014cites this paper
• Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man.

  2014cites this paper
• Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.

  2014cites this paper
• Chronic Treatment of Methimazole Alters Expression of Serotonin Receptors in Raphe Nuclei and Limbic System

  2014cites this paper
• Serotonin, serotonin receptors and their actions in insects

  2014cites this paper
• On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal.

  2014influential citation
• 5-HT2A/2C receptor modulation of absence seizures and characterization of the GHB-model

  2014influential citation
• Aryl Biphenyl‐3‐ylmethylpiperazines as 5‐HT7 Receptor Antagonists

  2013cites this paper
• 5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system

  2013influential citation
• Transactivation of platelet-derived growth factor receptor type β: Mechanisms and potential relevance in neurobiology

  2013cites this paper
• The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders

  2013cites this paper
• The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.

  2013cites this paper